Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

FDA clears SleepioRx for chronic insomnia

On Aug. 8, 2024, Big Health announced it received FDA clearance for its digital therapeutic, SleepioRx, for the treatment of chronic insomnia as an adjunct to usual care in adults. About SleepioRx SleepioRx is a prescription device that delivers cognitive behavioral therapy for [...]

2024-09-24T14:26:34-05:00August 9th, 2024|Industry|

FDA approves next-generation Inspire V therapy system

On Aug. 2, 2024, Inspire Medical Systems announced it received FDA approval for the Inspire V therapy system. About Inspire V System Inspire upper airway stimulation is used to treat patients with moderate to severe obstructive sleep apnea (OSA) who cannot tolerate PAP [...]

2024-09-24T14:29:31-05:00August 3rd, 2024|Industry|

ReactDx launches NiteWatch HSAT device

On Aug. 1, 2024, ReactDx announced the launch of NiteWatch, an FDA-cleared home sleep monitoring device. About NiteWatch NiteWatch is a home sleep test that measures oxygen saturation, photoplethysmogram, pulse rate, airflow, respiratory effort and heart rate variability. It is worn on the [...]

2024-09-24T14:30:50-05:00August 2nd, 2024|Industry|

FDA clears SANSA sleep apnea diagnostic patch

On July 31, 2024, Huxley Medical announced it received FDA 510(k) clearance for its chest-worn sleep apnea diagnostic patch, SANSA. About SANSA SANSA is a wearable device intended for use in recording, analysis and storage of biophysical parameters to aid in the evaluation of [...]

2024-09-24T14:31:47-05:00August 1st, 2024|Industry|

FDA approves WAKIX for narcolepsy in pediatric patients

On June 24, 2024, Harmony Biosciences announced FDA approval of its supplemental new drug application (sNDA) for pitolisant (WAKIX) tablets for the treatment of excessive daytime sleepiness (EDS) in pediatric patients aged 6 and older with narcolepsy. About pitolisant (WAKIX) Pitolisant is a [...]

2024-09-24T20:50:40-05:00June 25th, 2024|Industry|

FDA clears Oxevision sleep monitoring

On May 14, 2024, Oxehealth announced it received FDA 510(k) clearance for its contactless patient monitoring platform, Oxevision. About Oxevision Oxevision is sleep monitoring software that assesses video footage collected by a camera. It is an activity monitor designed to document and analyze physical [...]

2024-09-24T20:51:33-05:00May 15th, 2024|Industry|

Philips Respironics resolves personal injury claims

On April 29, Philips announced its first quarter results and announced it has reached an agreement to resolve the personal injury litigation and the medical monitoring class action in the U.S. According to a progress update report from the company, the settlement addresses approximately [...]

2024-05-06T13:39:28-05:00April 30th, 2024|Industry|

Beacon Biosignals receives FDA clearance for sleep staging software

On March 27, 2024, Beacon Biosignals announced it received FDA 510(k) clearance for SleepStage ML, its artificial intelligence (AI)/machine learning (ML) software that analyzes polysomnography (PSG) recordings and automatically scores sleep stages. About SleepStage ML According to a press release from the company, SleepStage [...]

2024-09-24T20:54:19-05:00March 28th, 2024|Industry|
Go to Top